Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Paclitaxel
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
First Patient Enrolled in DUBSTENT DIABETES Trial to Improve PCI Outcomes in Diabetics
Details : A combination of the Pantera™ Lux™ DCB Catheter (Paclitaxel-coated balloons), is being investigated for the treatment of diabetes mellitus.
Product Name : Pantera Lux DCB
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
September 11, 2025
Lead Product(s) : Paclitaxel
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Methylene Blue
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Recipient : Thomas Jefferson University
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Above the Cuff Suctioning During General Anesthesia
Details : Methylene Blue is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 01, 2011
Lead Product(s) : Methylene Blue
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Recipient : Thomas Jefferson University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
